QIAGEN N.V.QGEN

Market cap
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income14496130691171278040190-4135951342334184
Depreciation and amortization5870198199201191213216206231205215208205203
Non-cash impairments---------1401-134203
Amortization of debt discount and issuance costs-----20202536414232343018
Share-based compensation expense142025384228283440664138504744
Deferred tax (benefit) expense-20-32-23-68-41-37-6660-23-55-7-5-1011-23
Loss on marketable securities---------------0
Other items, net including fair value changes in derivatives-1514-11-3-19593-12-6-23-8-8
Accounts receivable7281415172512344240157-1555-12
Inventories-2162017423320223730108826245-88
Prepaid expenses and other current assets------52-7510-19-1-14-59-4-14
Other long-term assets34-0-013-3-417301-0-12-11
Accounts payable37-10-7-58-14798-6-2-221
Accrued and other current liabilities-2720-1326-21-26113-1320-22-72-18-56-9
Income taxes14635-24-160-1541-147-513227-26
Other long-term liabilities-55-6-4-63-8-24-1614-58-3417-4
Net cash provided by operating activities251245245259288317342287359331458639715459674
Purchases of property, plant and equipment80871028487987590110118133190129150167
Purchases of intangible assets4435263410201934411571721720134
Purchases of short-term investments1101874020420318496451568294503981,386976686
Proceeds from redemptions of short-term investments442436632763685341896923961813608831,271585
Cash paid for acquisitions, net of cash acquired3745713217116067905117368240-64150-
Proceeds From (Payments For) Collateral--------21-323-5345-10-6725
Purchases of investments, net-81984962359--3132
Other investing activities---1-469215-050-0-0-
Net cash used in investing activities-216-540-301-252-408-146-179-464-211-222-443-202-727-88-249
Proceeds from long-term debt, net of issuance costs3444000717--330--498-371-494
Repayment of long-term debt50470223872527--50629641480400602
Capital repayment--368612721-611057464100--292
Proceeds from exercise of call options related to cash convertible notes---------135240--37-
Payment of intrinsic value of cash convertible notes---------134237--37-
Tax withholding related to vesting of stock awards---------501424251834
Cash received (paid) for collateral liability------------13-1611
Cash paid for contingent consideration------------5--
Other financing activities1-8-6-4171-10-9-8-11-107---1
Net cash used in financing activities-35-311227-69193-259-11387360-639-50-150-126-434-423
Effect of exchange rate changes on cash and cash equivalents---------14-4-13-1-6
Net decrease in cash and cash equivalents----------530-31283-150-63-5
Cash paid for interest262117312421182026302522232024
Income Taxes Paid, Net3441621513342340294143102998216
Noncash or Part Noncash Equity Securities Acquired-----------3613-